Atropine Sulfate 0.01% Ophthalmic Solution is for topical ophthalmic use and used to dilate the eye before examination, surgery or to treat certain eye conditions.
- Volume: 6ml
- Concentration: 0.01 – 0.5% available
- We exclusively compound Atropine Sulfate 0.01% Ophthalmic Solution for ophthalmic use only
- Compounded in a sterile compounding facility that is <795>, <797> and <800> chapter compliant
References:
- Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1%, and 0.5%. Ophthalmology. 2014;121(1):175-181. PMID: 24064289. https://pubmed.ncbi.nlm.nih.gov/24064289/
- Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP Study): a randomized, double-blinded, placebo-controlled trial. Ophthalmology. 2019;126(1):113-124. PMID: 30122591. https://pubmed.ncbi.nlm.nih.gov/30122591/
- Tong L, Huang XL, Koh AL, et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation. Ophthalmology. 2009;116(3):572-579. PMID: 19167080. https://pubmed.ncbi.nlm.nih.gov/19167080/
- Cooper J, Schulman E, Jamal N. Current status on the development and treatment of myopia. Optometry. 2012;83(5):179-199. PMID: 22633343. https://pubmed.ncbi.nlm.nih.gov/22633343/
Learn More: Compounded Low-Dose Atropine Eye Drops
Contact us to inquire about customizations and for detailed pricing information. Please note that all compounds require a valid, patient-specific prescription.